InvestorsHub Logo
Followers 67
Posts 1297
Boards Moderated 0
Alias Born 08/12/2014

Re: Evaluate post# 36619

Thursday, 06/18/2015 9:25:12 AM

Thursday, June 18, 2015 9:25:12 AM

Post# of 703970
Fair enough, Evaluate that nobody would and should have that kind of information as you stated!

In biotech investing, only things matter are 1) does the company has a solid support financially? [My answer is yes. It is backed by Sir Neil Woodford, and others]; does the company's development is fundamentally sound and in competitive advantage [my answer is a yes, backed by all the information we have had today]; and does the company's market cap has been reflected fairly compared to its true market potential and that of its peer? [My answer is no, and it is well off at this point of time]

I don't care day to day up and down in price and from time to time throw a sword at someone who understandably swings trading. My thesis has had no change.

I have too many shares and call options, but I am ready to buy more call options if the price goes down; on the other hand, if the price continually goes up, I am okay with my decision of no action until the price reach certain high territory, for instance $30.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News